ArticleNPJ precision oncology2024

Targeting TYK2 alleviates Rab27A-induced malignant progression of non-small cell lung cancer via disrupting IFNα-TYK2-STAT-HSPA5 axis.

Yuanyuan Zeng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.